Developer docs
API playgroundTry for free, no card

Search company profiles

COFACTORY LIMITED

Full company profile

uuid025nf99

Namestring
COFACTORY LIMITED
Legal namestring
COFACTORY LTD
Websiteurl
cofactory.co.uk
Company typeenum
Private
Founded yearint
2024
Descriptiontext

COFACTORY LIMITED is a privately-held, boutique scientific consulting firm registered in England and Wales, operating from Manchester, UK. Founded in 2018 by Dr Paul Dobson (PhD Computational Biology) and Dr William Rowe (PhD Chemical Engineering), the firm delivers four interlocking service lines to biotech and life-sciences clients: Technology Development (Bioinformatics, AI, Cheminformatics, Process Modelling, Structural & Systems Biology, Chemometrics), Product Development (customer profiling, marketing strategy, sales channels, funnels, soft launches, pricing), Business Development (pitching, grants, fundraises, exits), and Strategy Development (technology transfer and commercialization infrastructure). Primary customer segments are academic spinouts, biotech startups, and — to a lesser extent — large multinationals seeking product management and AI capability support.

The firm's technology backbone is an interdisciplinary scientific platform spanning Life Sciences, Chemistry, Computer Science, and Process Engineering. AI is applied across engagements in the form of protein expression design, computer vision for cell phenotyping, knowledge graphs built on genome annotations, metabolic network reconstruction, and closed-loop optimization of cell culture media. Notable technical contributions include the AI-led protein expression design platform co-developed with Daresbury Proteins, the AI image analysis stack that supported ValitaCell's acquisition by Beckman Coulter Life Sciences in 2022, and the CELLIMAGE consortium that produced Intel's AI Connect for Scientific Data (AiCSD). The firm's R&D output is supported by more than 50 peer-reviewed publications from the founders and over £8M in non-dilutive grant funding secured for partners across multiple projects.

Commercially, Cofactory runs a freemium-to-advisory model: startups receive free initial consultations and advice, with monetisation occurring later through paid advisory positions, project-based technology development, and longer-term consulting engagements. The firm does not publish pricing, derives revenue from professional services across grant-funded projects, startup mandates, and government commissions, and operates without institutional investment. Geographic focus is the United Kingdom, particularly the NW England biotech cluster, with targeted international collaborations (Ireland via CELLIMAGE/DTIF, EU/multinational projects via Intel and Waters). Customers span startups (Daresbury Proteins, ValitaCell, Multus Biotechnology, CELLIMAGE), government programs (InnovateUK, UK Medicines Discovery Catapult, LYVA Labs, iiCON), and academic institutions (University of Salford/IBIC, Liverpool School of Tropical Medicine).

Short descriptiontext

COFACTORY LIMITED is a privately-held Manchester-based scientific consultancy that provides technology, product, business, and strategy development advisory services to biotech startups, academic spinouts, and government innovation programs across the UK.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersManchester, United Kingdom
HQ citystring
Manchester
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biotech consulting, bioinformatics advisory, life sciences consulting, technology transfer services, process modelling consulting
Industry2 codes
PRIMARYHLAGAOAK
CMC, Process Development & Tech Transfer Staffing FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAI
Laboratory, Bioanalytical & Central Lab Staffing FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code3 codes
  • Other Scientific and Technical Consulting Services54169
  • Management Consulting Services54161
  • Professional, Scientific, and Technical Services54
SIC code2 codes
  • Services-Management Consulting Services8742
  • Services-Commercial Physical & Biological Research8731
Product category
Biotech Consulting
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Advisory Services
TypeProfessional Services
Description

Paid advisory positions and services after initial free consultations. The company states their payoff comes through paid advisory positions and services rather than upfront charging.

cofactory.co.uk
2Technology Development Projects
TypeProfessional Services
Description

Project-based technology development work across Bioinformatics, AI, and Process Modelling for biotech partners

cofactory.co.uk
3Product Development Consulting
TypeProfessional Services
Description

Support for customer profiling, marketing strategy, sales channels, soft launches, and pricing

cofactory.co.uk
4Business Development Advisory
TypeProfessional Services
Description

Support for spinouts and startups on pitching, grants, fundraises, and exits

cofactory.co.uk
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Free initial consultation for startups
ModelFreemiumBilling cadenceMulti-year contract
Notes

Startups receive free initial discussions and advice. The company's payoff comes later through paid advisory positions and services.

cofactory.co.uk
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Cofactory provides interdisciplinary scientific consulting services to biotech and life sciences companies. Its work spans four service lines: Technology Development (Bioinformatics, AI, Cheminformatics, Process Modelling), Product Development (customer profiling, marketing, sales channels, soft launches, pricing), Business Development (pitching, grants, fundraising, exits), and Strategy Development (technology transfer and commercialisation infrastructure). The firm operates across all Technology Readiness Levels (TRLs) and supports academic spinouts, startups, and multinational clients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Secured >£8M in non-dilutive grant funding for partners
+3 more records
Product overview1 text field

COFACTORY LIMITED is a consultancy firm providing interdisciplinary scientific advisory services to biotech companies, not a traditional product company. The core offerings consist of four service lines: Technology Development (Bioinformatics, AI, Process Modelling), Product Development (customer profiling, marketing, sales), Business Development (pitching, grants, fundraising, exits), and Strategy Development (technology transfer, commercialisation). Projects include AI-led protein expression platforms (Daresbury Proteins), AI analytics for stem cell therapy manufacturing (CELLIMAGE), and biopharma market expansion support (Multus Biotechnology).

Product and service1 record
1Technology Development Services
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Acquired ValitaCell in 2022, where Cofactory built and led the Data Team driving new technology for cell phenotyping and AI image analysis. Cofactory also supported ValitaCell's soft product launches and exit process.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-05-28
Description

Joint InnovateUK BridgeAI grant developing AI-led protein expression design platforms to produce growth factors for Cellular Agriculture and Cell Therapy Manufacturing. The collaboration aims to drive down the cost of proteins needed for Cultivated Meat and Biopharmaceutical manufacturing.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

CELLIMAGE project collaboration funded by Irish government DTIF grant to develop AI analytics for Stem Cell Therapy manufacturing. Cofactory ideated and funded the project, built the AI team, and led laboratory and software development interactions.

Strategic tierCoreTypeTechnology or Integration
Description

Technology partner in CELLIMAGE project that created AI Connect for Scientific Data (AiCSD) - a connectivity solution for Edge AI workloads developed by Intel based on the project outcomes.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Supporting expansion into Biopharma by designing marketing content, building customer funnels, overseeing sales strategies, and supporting fundraising efforts. Multus designs cell culture media using lab robotics and AI in a closed-loop optimisation platform.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Commissioned to report on Sustainability issues and opportunities in Biopharmaceutical Manufacturing, with findings that the majority of emissions are associated with energy costs of filtering air (HVAC) and water (water-for-injection grade).

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Supported IBIC Relationship Development project to help university academics align around a business canvas and pitch deck to commercialize their Plant Natural Product Extraction expertise.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Liverpool City Region's Innovation Agency. Provided domain expertise to profile Industrial Biotechnology academics, companies and stakeholders, formulating plans to increase academic-company interactions and support bioprocess scaleup.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership to understand Data Science and Informatics barriers holding back microbiome research translation. Designed and led three workshops on Personal Care; Food, Water and the Process Industries; and One Health.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

BRITE initiative led by LSTMED, funded by Research England, to drive biopharmaceutical manufacturing in NW England. Cofactory is part of this new initiative.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Enterprise scientific R&D platform combining software, data, and services for life sciences. Overlaps with Cofactory's informatics, data, and AI integration offerings but at much larger scale and with proprietary software assets.

TypeDirect peer
Description

UK-based scientific software and services firm specializing in cheminformatics, computational chemistry, and molecular design. Directly comparable to Cofactory's cheminformatics, computational biology, and AI/Process Modelling capabilities serving biotech clients.

TypeBroad incumbent
Description

UK-based independent consulting firm with significant life sciences and energy practices. Comparable in client base (UK corporates, government-linked initiatives) and consulting-driven model, though much broader in scope.

TypeEmerging player
Description

UK startup using AI and lab robotics to design cell culture media for cultivated meat and biopharma. Functions partly as a Cofactory client (commercial expansion support) but also a thematic peer in AI-driven bioprocess optimization.

TypeBroad incumbent
Description

Deep-tech product development and consulting firm with significant biotech and process engineering capabilities. Comparable to Cofactory's interdisciplinary Life Sciences/Computer Science/Process Engineering model but at much larger scale.

TypeDirect peer
Description

UK-based biotech and pharmaceutical consulting firm offering strategic and technical advisory to biotechs and investors. Highly comparable to Cofactory in client profile (spinouts, startups, pharma) and service mix (commercial strategy, due diligence, scientific advisory).

TypeRegional player
Description

UK Catapult center accelerating drug discovery by providing infrastructure, expertise, and project support to biotechs. Cofactory has been commissioned by MDC, making it both a peer and a prior client; both operate at the intersection of UK biotech translation.

8Kinapse (Syneos Health Consulting)
TypeBroad incumbent
Description

Global life sciences consulting firm (now part of Syneos) offering strategy, regulatory, and operational advisory to pharma and biotech. Comparable in advisory nature but vastly larger in scale and operating globally.

TypeRegional player
Description

UK Catapult accelerating cell and gene therapy commercialization. Highly relevant peer given Cofactory's work on stem cell therapy manufacturing AI analytics (CELLIMAGE) and bioprocessing scaleup support.

10Oxford BioConsultancy
TypeDirect peer
Description

UK boutique life sciences consulting firm supporting biotech startups, spinouts, and pharma on strategic and scientific issues. Closely comparable to Cofactory in size, focus on academic spinouts, and breadth of advisory services.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

COFACTORY LIMITED

Biotech Consultingcofactory.co.uk

COFACTORY LIMITED is a privately-held Manchester-based scientific consultancy that provides technology, product, business, and strategy development advisory services to biotech startups, academic spinouts, and government innovation programs across the UK.

What COFACTORY LIMITED does

COFACTORY LIMITED is a privately-held, boutique scientific consulting firm registered in England and Wales, operating from Manchester, UK. Founded in 2018 by Dr Paul Dobson (PhD Computational Biology) and Dr William Rowe (PhD Chemical Engineering), the firm delivers four interlocking service lines to biotech and life-sciences clients: Technology Development (Bioinformatics, AI, Cheminformatics, Process Modelling, Structural & Systems Biology, Chemometrics), Product Development (customer profiling, marketing strategy, sales channels, funnels, soft launches, pricing), Business Development (pitching, grants, fundraises, exits), and Strategy Development (technology transfer and commercialization infrastructure). Primary customer segments are academic spinouts, biotech startups, and — to a lesser extent — large multinationals seeking product management and AI capability support.

The firm's technology backbone is an interdisciplinary scientific platform spanning Life Sciences, Chemistry, Computer Science, and Process Engineering. AI is applied across engagements in the form of protein expression design, computer vision for cell phenotyping, knowledge graphs built on genome annotations, metabolic network reconstruction, and closed-loop optimization of cell culture media. Notable technical contributions include the AI-led protein expression design platform co-developed with Daresbury Proteins, the AI image analysis stack that supported ValitaCell's acquisition by Beckman Coulter Life Sciences in 2022, and the CELLIMAGE consortium that produced Intel's AI Connect for Scientific Data (AiCSD). The firm's R&D output is supported by more than 50 peer-reviewed publications from the founders and over £8M in non-dilutive grant funding secured for partners across multiple projects.

Commercially, Cofactory runs a freemium-to-advisory model: startups receive free initial consultations and advice, with monetisation occurring later through paid advisory positions, project-based technology development, and longer-term consulting engagements. The firm does not publish pricing, derives revenue from professional services across grant-funded projects, startup mandates, and government commissions, and operates without institutional investment. Geographic focus is the United Kingdom, particularly the NW England biotech cluster, with targeted international collaborations (Ireland via CELLIMAGE/DTIF, EU/multinational projects via Intel and Waters). Customers span startups (Daresbury Proteins, ValitaCell, Multus Biotechnology, CELLIMAGE), government programs (InnovateUK, UK Medicines Discovery Catapult, LYVA Labs, iiCON), and academic institutions (University of Salford/IBIC, Liverpool School of Tropical Medicine).

COFACTORY LIMITED firmographics

Firmographics
Name
COFACTORY LIMITED
Legal name
COFACTORY LTD
Website
https://cofactory.co.uk
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
1–10 employees
Short description
COFACTORY LIMITED is a privately-held Manchester-based scientific consultancy that provides technology, product, business, and strategy development advisory services to biotech startups, academic spinouts, and government innovation programs across the UK.
Ownership category
akta.pro rank

COFACTORY LIMITED industry classification

Industry
Product category
Biotech Consulting
NAICS
Other Scientific and Technical Consulting Services (54169), Management Consulting Services (54161), Professional, Scientific, and Technical Services (54)
SIC
Services-Management Consulting Services (8742), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAOAK
CMC, Process Development & Tech Transfer Staffing FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAI
Laboratory, Bioanalytical & Central Lab Staffing FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Biotech consulting
  • Bioinformatics advisory
  • Life sciences consulting
  • Technology transfer services
  • Process modelling consulting

Where COFACTORY LIMITED is headquartered

Location

Headquarters

HQ city
Manchester
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

COFACTORY LIMITED business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Advisory Services: Paid advisory positions and services after initial free consultations. The company states their payoff comes through paid advisory positions and services rather than upfront charging.
  2. Technology Development Projects: Project-based technology development work across Bioinformatics, AI, and Process Modelling for biotech partners
  3. Product Development Consulting: Support for customer profiling, marketing strategy, sales channels, soft launches, and pricing
  4. Business Development Advisory: Support for spinouts and startups on pitching, grants, fundraises, and exits

Pricing tiers

ModelBillingPrice
FreemiumMulti-year contractFree initial consultation for startups

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

COFACTORY LIMITED product offering

Product offering

Core offering

Cofactory provides interdisciplinary scientific consulting services to biotech and life sciences companies. Its work spans four service lines: Technology Development (Bioinformatics, AI, Cheminformatics, Process Modelling), Product Development (customer profiling, marketing, sales channels, soft launches, pricing), Business Development (pitching, grants, fundraising, exits), and Strategy Development (technology transfer and commercialisation infrastructure). The firm operates across all Technology Readiness Levels (TRLs) and supports academic spinouts, startups, and multinational clients.

Product overview

COFACTORY LIMITED is a consultancy firm providing interdisciplinary scientific advisory services to biotech companies, not a traditional product company. The core offerings consist of four service lines: Technology Development (Bioinformatics, AI, Process Modelling), Product Development (customer profiling, marketing, sales), Business Development (pitching, grants, fundraising, exits), and Strategy Development (technology transfer, commercialisation). Projects include AI-led protein expression platforms (Daresbury Proteins), AI analytics for stem cell therapy manufacturing (CELLIMAGE), and biopharma market expansion support (Multus Biotechnology).

Differentiator

Problem solved

Functional benefit

Products and services

  • Technology Development Services

Quantifiable outcome

  • Secured >£8M in non-dilutive grant funding for partners
  • +3 more outcomes

Companies that use COFACTORY LIMITED

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles3 records

COFACTORY LIMITED technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature4 records

COFACTORY LIMITED partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • Beckman Coulter Life SciencescoreStrategic or Co-development Partner · 1 January 2022Acquired ValitaCell in 2022, where Cofactory built and led the Data Team driving new technology for cell phenotyping and AI image analysis. Cofactory also supported ValitaCell's soft product launches and exit process.
  • Daresbury ProteinscoreStrategic or Co-development Partner · 28 May 2019Joint InnovateUK BridgeAI grant developing AI-led protein expression design platforms to produce growth factors for Cellular Agriculture and Cell Therapy Manufacturing. The collaboration aims to drive down the cost of proteins needed for Cultivated Meat and Biopharmaceutical manufacturing.
  • University of GalwaycoreStrategic or Co-development PartnerCELLIMAGE project collaboration funded by Irish government DTIF grant to develop AI analytics for Stem Cell Therapy manufacturing. Cofactory ideated and funded the project, built the AI team, and led laboratory and software development interactions.
  • IntelcoreTechnology or IntegrationTechnology partner in CELLIMAGE project that created AI Connect for Scientific Data (AiCSD) - a connectivity solution for Edge AI workloads developed by Intel based on the project outcomes.
  • Multus Biotechnology LtdcoreStrategic or Co-development PartnerSupporting expansion into Biopharma by designing marketing content, building customer funnels, overseeing sales strategies, and supporting fundraising efforts. Multus designs cell culture media using lab robotics and AI in a closed-loop optimisation platform.
  • UK Medicines Discovery CatapultminorImplementation/ SI/ Consulting PartnerCommissioned to report on Sustainability issues and opportunities in Biopharmaceutical Manufacturing, with findings that the majority of emissions are associated with energy costs of filtering air (HVAC) and water (water-for-injection grade).
  • University of Salford & IBICminorImplementation/ SI/ Consulting PartnerSupported IBIC Relationship Development project to help university academics align around a business canvas and pitch deck to commercialize their Plant Natural Product Extraction expertise.
  • LYVA LabsminorStrategic or Co-development PartnerLiverpool City Region's Innovation Agency. Provided domain expertise to profile Industrial Biotechnology academics, companies and stakeholders, formulating plans to increase academic-company interactions and support bioprocess scaleup.
  • iiCONminorStrategic or Co-development PartnerPartnership to understand Data Science and Informatics barriers holding back microbiome research translation. Designed and led three workshops on Personal Care; Food, Water and the Process Industries; and One Health.
  • Liverpool School of Tropical MedicinecoreStrategic or Co-development PartnerBRITE initiative led by LSTMED, funded by Research England, to drive biopharmaceutical manufacturing in NW England. Cofactory is part of this new initiative.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

COFACTORY LIMITED competitors and assessment

Company assessment

Broad incumbents

  • Dotmatics: Enterprise scientific R&D platform combining software, data, and services for life sciences. Overlaps with Cofactory's informatics, data, and AI integration offerings but at much larger scale and with proprietary software assets.
  • Baringa Partners: UK-based independent consulting firm with significant life sciences and energy practices. Comparable in client base (UK corporates, government-linked initiatives) and consulting-driven model, though much broader in scope.
  • Cambridge Consultants: Deep-tech product development and consulting firm with significant biotech and process engineering capabilities. Comparable to Cofactory's interdisciplinary Life Sciences/Computer Science/Process Engineering model but at much larger scale.
  • Kinapse (Syneos Health Consulting): Global life sciences consulting firm (now part of Syneos) offering strategy, regulatory, and operational advisory to pharma and biotech. Comparable in advisory nature but vastly larger in scale and operating globally.

Direct peers

  • Cresset (Discovery Services): UK-based scientific software and services firm specializing in cheminformatics, computational chemistry, and molecular design. Directly comparable to Cofactory's cheminformatics, computational biology, and AI/Process Modelling capabilities serving biotech clients.
  • Alacrita: UK-based biotech and pharmaceutical consulting firm offering strategic and technical advisory to biotechs and investors. Highly comparable to Cofactory in client profile (spinouts, startups, pharma) and service mix (commercial strategy, due diligence, scientific advisory).
  • Oxford BioConsultancy: UK boutique life sciences consulting firm supporting biotech startups, spinouts, and pharma on strategic and scientific issues. Closely comparable to Cofactory in size, focus on academic spinouts, and breadth of advisory services.

Emerging players

  • Multus Biotechnology: UK startup using AI and lab robotics to design cell culture media for cultivated meat and biopharma. Functions partly as a Cofactory client (commercial expansion support) but also a thematic peer in AI-driven bioprocess optimization.

Regional players

  • Medicines Discovery Catapult: UK Catapult center accelerating drug discovery by providing infrastructure, expertise, and project support to biotechs. Cofactory has been commissioned by MDC, making it both a peer and a prior client; both operate at the intersection of UK biotech translation.
  • Cell & Gene Therapy Catapult: UK Catapult accelerating cell and gene therapy commercialization. Highly relevant peer given Cofactory's work on stem cell therapy manufacturing AI analytics (CELLIMAGE) and bioprocessing scaleup support.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

COFACTORY LIMITED social profiles

Digital presence

COFACTORY LIMITED financial estimates

Financial estimate

Revenue estimate

Valuation estimate

COFACTORY LIMITED leadership team

Management profile

Number of profiles

Profiles2 records

COFACTORY LIMITED funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

COFACTORY LIMITED M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about COFACTORY LIMITED

What does COFACTORY LIMITED do?

Cofactory provides interdisciplinary scientific consulting services to biotech and life sciences companies. Its work spans four service lines: Technology Development (Bioinformatics, AI, Cheminformatics, Process Modelling), Product Development (customer profiling, marketing, sales channels, soft launches, pricing), Business Development (pitching, grants, fundraising, exits), and Strategy Development (technology transfer and commercialisation infrastructure). The firm operates across all Technology Readiness Levels (TRLs) and supports academic spinouts, startups, and multinational clients.

Is COFACTORY LIMITED a public or private company?

COFACTORY LIMITED is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was COFACTORY LIMITED founded?

COFACTORY LIMITED was founded in 2024. It employs 1 to 10 people.

Where is COFACTORY LIMITED based?

COFACTORY LIMITED is headquartered in Manchester, United Kingdom, in the Europe region.

How does COFACTORY LIMITED make money?

Four revenue lines are on record. Advisory Services are the primary driver. The others are technology Development Projects, product Development Consulting and business Development Advisory.

Who are COFACTORY LIMITED's main competitors?

Broad incumbents on record are Dotmatics, Baringa Partners, Cambridge Consultants and Kinapse (Syneos Health Consulting). Direct peers are Cresset (Discovery Services), Alacrita and Oxford BioConsultancy. Multus Biotechnology is listed as an emerging player. Regional players are Medicines Discovery Catapult and Cell & Gene Therapy Catapult.

Does COFACTORY LIMITED have an API?

No public API is recorded for COFACTORY LIMITED.

What industry is COFACTORY LIMITED in?

COFACTORY LIMITED's product category is Biotech Consulting. Its primary akta.pro industry code is HLAGAOAK, CMC, Process Development & Tech Transfer Staffing FSP, with a secondary code of HLAGAOAI, Laboratory, Bioanalytical & Central Lab Staffing FSP. Its NAICS code is 54169 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales